CELLBXHEALTH PLC (CLBX) — research page
UK · uk-cm-kg/AIM/CLBX · as of 2026-11-06
Identity and listing
The issuer is CELLBXHEALTH PLC, listed on AIM under ticker CLBX, with ISIN GB0034330679 and LEI 213800BY11K6W3NMS374. Its security type is Corporate, its segment is ASX1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | CELLBXHEALTH PLC | source · 2026-11-06 |
| exchange | AIM | source · 2026-11-06 |
| ticker | CLBX | source · 2026-11-06 |
| ISIN | GB0034330679 | source · 2026-11-06 |
| LEI | 213800BY11K6W3NMS374 | source · 2026-11-09 |
| security type | Corporate | source · 2026-11-06 |
| segment | ASX1 | source · 2026-11-06 |
| sector | Pharmaceuticals and Biotechnology [201030] | source · 2026-11-06 |
| jurisdiction | England and Wales (Companies House jurisdiction field) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 48 filings across 36 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 6 days. The latest filing is dated 2026-10-21, a financial statement, 16 days before the record date of 2026-11-06. The AIM median cadence gap is 7.0 days across 594 issuers, and the AIM median latency is 4 days. The sector median cadence gap is 6.0 days across 51 issuers, and the sector median latency is 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 48 | 6 | 16 |
| exchange median: AIM (594 issuers) | 33.5 | 7 | 4 |
| sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers) | 42 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-21 | financial_statement | Q3 Trading Update and FY 2026 Outlook | |
| 2026-10-21 | regulatory_announcement | Master Services Agreement with Swiss biotech co | |
| 2026-10-14 | regulatory_announcement | New Statement of Work with US-Based Pharma Company | |
| 2026-08-11 | regulatory_announcement | Parsortix CTCs used for Brain Cancer detection | |
| 2026-08-03 | regulatory_announcement | Parsortix CTCs used for ADC target assessment |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is MHA, and its location is not on the record. Auditor changes are not on the record, as the market's record does not yet carry a lifecycle type map for this register.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as the market's index does not yet carry a lifecycle type map for this register. The halt flag is listed, not halted.
Orderability
Under rule version acm-68000/uk/product-governance-fca-prod-sourcebook/r1, as of chapter date 2026-11-04, the signal ACM-200 is determinable for elective professional client and for eligible counterparty.
| client category | outcome |
|---|---|
| elective professional client | ACM-200 |
| eligible counterparty | ACM-200 |
rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations page, count 0.
Open research
No openly published research notes were found, count 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. The issuer has no sealed years, and the market has no earliest sealed date. The live record began on 2026-09-11. Years 2021 to 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
- 10.2
- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/CLBX (identity.isin)
- 10.3
- https://find-and-update.company-information.service.gov.uk/company/04985171 (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://www.londonstockexchange.com/stock/CLBX/cellbxhealth-plc/company-page (identity.sector)
- 10.6
- https://mcp.uk-cm-kg.ai/events/AIM/CLBX (the disclosure lines)
- 10.7
- https://marketsecurities.fca.org.uk/officiallist (the halt flag)
- 10.8
- https://find-and-update.company-information.service.gov.uk/company/04985171/filing-history/MzUzMTY3MTgzNmFkaXF6a2N4/document?format=pdf&download=0 (the auditor)
- 10.9
- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.10
- https://mcp.uk-cm-kg.ai/record/AIM/CLBX (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"GB0034330679"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:e1e0803d1c5dbc08.